Urmăriți
Oskar Hansson
Oskar Hansson
Professor of Neurology, Lund University
Adresă de e-mail confirmată pe med.lu.se - Pagina de pornire
Titlu
Citat de
Citat de
Anul
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson, H Zetterberg, P Buchhave, E Londos, K Blennow, L Minthon
The Lancet Neurology 5 (3), 228-234, 2006
21062006
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment
N Mattsson, H Zetterberg, O Hansson, N Andreasen, L Parnetti, ...
Jama 302 (4), 385-393, 2009
14222009
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
TK Karikari, TA Pascoal, NJ Ashton, S Janelidze, AL Benedet, ...
The Lancet Neurology 19 (5), 422-433, 2020
7842020
Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
S Janelidze, N Mattsson, S Palmqvist, R Smith, TG Beach, GE Serrano, ...
Nature medicine 26 (3), 379-386, 2020
7832020
Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders
S Palmqvist, S Janelidze, YT Quiroz, H Zetterberg, F Lopera, E Stomrud, ...
Jama 324 (8), 772-781, 2020
7602020
Cerebrospinal fluid levels ofβ-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia
P Buchhave, L Minthon, H Zetterberg, ÅK Wallin, K Blennow, O Hansson
Archives of general psychiatry 69 (1), 98-106, 2012
7502012
Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease
MM Zeron, O Hansson, N Chen, CL Wellington, BR Leavitt, P Brundin, ...
Neuron 33 (6), 849-860, 2002
7382002
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
S Palmqvist, M Schöll, O Strandberg, N Mattsson, E Stomrud, H Zetterberg, ...
Nature communications 8 (1), 1214, 2017
6912017
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
GB Frisoni, M Boccardi, F Barkhof, K Blennow, S Cappa, K Chiotis, ...
The Lancet Neurology 16 (8), 661-676, 2017
5982017
Brain charts for the human lifespan
RAI Bethlehem, J Seidlitz, SR White, JW Vogel, KM Anderson, ...
Nature 604 (7906), 525-533, 2022
5772022
Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity
D Lindqvist, S Janelidze, P Hagell, S Erhardt, M Samuelsson, L Minthon, ...
Biological psychiatry 66 (3), 287-292, 2009
5632009
Plasma β-amyloid in Alzheimer’s disease and vascular disease
S Janelidze, E Stomrud, S Palmqvist, H Zetterberg, D Van Westen, ...
Scientific reports 6 (1), 26801, 2016
5432016
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts
O Hansson, J Seibyl, E Stomrud, H Zetterberg, JQ Trojanowski, T Bittner, ...
Alzheimer's & dementia 14 (11), 1470-1481, 2018
5332018
Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people
G De Meyer, F Shapiro, H Vanderstichele, E Vanmechelen, ...
Archives of neurology 67 (8), 949-956, 2010
5272010
Amyloid biomarkers in Alzheimer's disease
K Blennow, N Mattsson, M Schöll, O Hansson, H Zetterberg
Trends in pharmacological sciences 36 (5), 297-309, 2015
5222015
Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis
C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ...
JAMA neurology 76 (9), 1035-1048, 2019
5142019
Two randomized phase 3 studies of aducanumab in early Alzheimer’s disease
S Budd Haeberlein, PS Aisen, F Barkhof, S Chalkias, T Chen, S Cohen, ...
The journal of prevention of Alzheimer's disease 9 (2), 197-210, 2022
4942022
Biomarkers for neurodegenerative diseases
O Hansson
Nature medicine 27 (6), 954-963, 2021
4832021
Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders
S Hall, A Öhrfelt, R Constantinescu, U Andreasson, Y Surova, F Bostrom, ...
Archives of neurology 69 (11), 1445-1452, 2012
4632012
CSF and blood biomarkers for Parkinson's disease
L Parnetti, L Gaetani, P Eusebi, S Paciotti, O Hansson, O El-Agnaf, ...
The Lancet Neurology 18 (6), 573-586, 2019
4462019
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20